79320342 - LBIOME

Information

• Trademark
• 79320342

• Source

• Serial Number

  79320342

• Registration Number

  7033011

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 20, 2021
  3 years ago

• Registration Date

  April 25, 2023
  a year ago

• Transaction Date

  January 10, 2025
  2 months ago

• Status Date

  April 25, 2023
  a year ago

• Published for Opposition Date

  February 07, 2023
  2 years ago

• Location Date

  February 07, 2023
  2 years ago

• Status Code

  700

• Current Location

  PETITIONS OFFICE

  Employee Name

  AYALA, LOURDES

• Attorney Docket Number

  4662-4622

  Attorney Name

  Duane M. Byers

  Law Office Assigned Location Code

  L60

• Owners

  • ADARE PHARMACEUTICALS S.A.S

Case File Statements

• GS0401: Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use
• DM0000: The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle.
• GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics

Case File Event Statements

• 9/24/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/16/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 9/28/2021 - 3 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/1/2022 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/10/2022 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/11/2022 - 3 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/9/2022 - 3 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/9/2022 - 3 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/27/2022 - 3 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/26/2022 - 2 years ago

  10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/26/2022 - 2 years ago

  11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/26/2022 - 2 years ago

  12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/26/2022 - 2 years ago

  13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/26/2022 - 2 years ago

  14 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 8/5/2022 - 2 years ago

  15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/5/2022 - 2 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/5/2022 - 2 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/3/2022 - 2 years ago

  18 - FINAL REFUSAL WRITTEN Type: CNFR

• 9/3/2022 - 2 years ago

  19 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/3/2022 - 2 years ago

  20 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 12/30/2022 - 2 years ago

  21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 12/30/2022 - 2 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/31/2022 - 2 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/4/2023 - 2 years ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/17/2023 - 2 years ago

  27 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 1/18/2023 - 2 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/18/2023 - 2 years ago

  26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/18/2023 - 2 years ago

  28 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/30/2023 - 2 years ago

  29 - ASSIGNED TO PETITION STAFF Type: APET

• 2/1/2023 - 2 years ago

  30 - POST PUBLICATION AMENDMENT RECEIVED Type: PPAR

• 2/1/2023 - 2 years ago

  31 - ASSIGNED TO PETITION STAFF Type: APET

• 2/7/2023 - 2 years ago

  32 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/7/2023 - 2 years ago

  33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/7/2023 - 2 years ago

  34 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/7/2023 - 2 years ago

  35 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 2/22/2023 - 2 years ago

  36 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 2/22/2023 - 2 years ago

  37 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/14/2023 - 2 years ago

  38 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 4/25/2023 - a year ago

  40 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 4/25/2023 - a year ago

  39 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/2/2023 - a year ago

  43 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/2/2023 - a year ago

  42 - FINAL DISPOSITION PROCESSED Type: FIMP

• 8/20/2023 - a year ago

  44 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/25/2023 - a year ago

  41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/4/2023 - a year ago

  48 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 7/19/2024 - 8 months ago

  49 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 11/15/2024 - 4 months ago

  50 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/6/2023 - a year ago

  47 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/6/2023 - a year ago

  45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/6/2023 - a year ago

  46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA